DCM
Driehaus Capital Management Portfolio holdings
AUM
$12.5B
1-Year Return
79.21%
This Quarter Return
+4.28%
1 Year Return
+79.21%
3 Year Return
+526.69%
5 Year Return
+1,716.36%
10 Year Return
+17,720.68%
AUM
$7.69B
AUM Growth
-$229M
(-2.9%)
Cap. Flow
+$61.7M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
18.39%
Holding
466
New
86
Increased
134
Reduced
143
Closed
77
Top Buys
| 1 |
Camtek
CAMT
|
$87.9M |
| 2 |
Structure Therapeutics
GPCR
|
$63.2M |
| 3 |
Tidewater
TDW
|
$56M |
| 4 |
Onto Innovation
ONTO
|
$48.4M |
| 5 |
Noble Corp
NE
|
$44.7M |
Top Sells
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$94.7M |
| 2 |
Iridium Communications
IRDM
|
$61.9M |
| 3 |
Wingstop
WING
|
$49.8M |
| 4 |
Axcelis
ACLS
|
$42.9M |
| 5 |
Shift4
FOUR
|
$42.3M |
Sector Composition
| 1 | Technology | 23.55% |
| 2 | Industrials | 20.08% |
| 3 | Healthcare | 18.29% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Consumer Staples | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Mondelez International
MDLZ
$79.9B
| $499K | 0.01% |
+7,195
| New | +$499K |
|
352
McKesson
MCK
$85.5B
| $496K | 0.01% |
+1,141
| New | +$496K |
|
353
Boston Scientific
BSX
$159B
| $496K | 0.01% |
9,396
+1,236
| +15% | +$65.3K |
|
354
Global Payments
GPN
$21.3B
| $467K | 0.01% |
+4,047
| New | +$467K |
|
355
On Holding
ONON
$14.9B
| $425K | 0.01% |
15,281
+8,675
| +131% | +$241K |
|
356
Marriott International Class A Common Stock
MAR
$71.9B
| $413K | 0.01% |
2,103
-956
| -31% | -$188K |
|
357
Galapagos
GLPG
$2.2B
| $388K | 0.01% |
11,235
| – | – |
|
358
Amphenol
APH
$135B
| $380K | ﹤0.01% |
+9,052
| New | +$380K |
|
359
Equinix
EQIX
$75.7B
| $374K | ﹤0.01% |
515
+182
| +55% | +$132K |
|
360
Applied Materials
AMAT
$130B
| $373K | ﹤0.01% |
2,695
-678
| -20% | -$93.9K |
|
361
Calidi Biotherapeutics
CLDI
$8.56M
| $360K | ﹤0.01% |
789
+221
| +39% | +$101K |
|
362
Eli Lilly
LLY
$652B
| $324K | ﹤0.01% |
604
-918
| -60% | -$493K |
|
363
Zimmer Biomet
ZBH
$20.9B
| $303K | ﹤0.01% |
+2,696
| New | +$303K |
|
364
Schlumberger
SLB
$53.4B
| $295K | ﹤0.01% |
+5,068
| New | +$295K |
|
365
Lufax Holding
LU
$2.61B
| $293K | ﹤0.01% |
+69,146
| New | +$293K |
|
366
General Motors
GM
$55.5B
| $293K | ﹤0.01% |
+8,885
| New | +$293K |
|
367
Eaton
ETN
$136B
| $283K | ﹤0.01% |
1,326
-23
| -2% | -$4.91K |
|
368
IBM
IBM
$232B
| $280K | ﹤0.01% |
+1,994
| New | +$280K |
|
369
Ferguson
FERG
$47.8B
| $270K | ﹤0.01% |
1,643
-1,475
| -47% | -$243K |
|
370
American International
AIG
$43.9B
| $256K | ﹤0.01% |
4,226
+331
| +8% | +$20.1K |
|
371
Valero Energy
VLO
$48.7B
| $250K | ﹤0.01% |
+1,764
| New | +$250K |
|
372
Accenture
ACN
$159B
| $243K | ﹤0.01% |
792
-83
| -9% | -$25.5K |
|
373
Merck
MRK
$212B
| $240K | ﹤0.01% |
2,331
-1,211
| -34% | -$125K |
|
374
Jabil
JBL
$22.5B
| $237K | ﹤0.01% |
+1,871
| New | +$237K |
|
375
PepsiCo
PEP
$200B
| $237K | ﹤0.01% |
+1,399
| New | +$237K |
|